Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate

Author: Benzinga Newsdesk | March 29, 2024 12:56am
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.68) by 161.76 percent. This is a 25.83 percent increase over losses of $(2.40) per share from the same period last year.

Posted In: BJDX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist